Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Cebado cortical para optimizar la rehabilitación de la marcha en el ictus: una renovación

12 de noviembre de 2026 actualizado por: University of Illinois Chicago

Cebado cortical para optimizar la rehabilitación de la marcha: Renovación

Achieving functional ambulation post stroke continues to be a challenge for stroke survivors, clinicians, and researchers. In the effort to enhance outcomes of motor training, cortical priming using brain stimulation has emerged as a promising adjuvant to conventional rehabilitation. This project focuses on the development of a long term gait rehabilitation protocol using brain stimulation to improve walking outcomes in people with stroke. The project will also aim to understand the neural mechanisms that are associated with response to the intervention.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Actual)

58

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Illinois
      • Chicago, Illinois, Estados Unidos, 60612
        • Physical Therapy

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Age greater than 18 years
  • First ever monohemispheric stroke > 3 months since onset
  • Residual hemiparetic gait deficits (e.g. abnormal gait pattern)
  • Able to walk for 5 minutes at self-paced speed. Handheld assistive device is acceptable.
  • Walking speed lesser than 1.2 m/s
  • Lower limb Fugl-Meyer Motor score between 15-30
  • At least 5 deg of ankle dorsiflexion necessary to perform the ankle-tracking task

Exclusion Criteria:

  • General exclusion criteria

    • Severe osteoporosis
    • Contracture-limiting range of motion of lower limb
    • Score of more than 2 on the Modified Ashworth Scale (indicating increased muscle tone through ankle range of motion)
    • Uncontrolled anti-spasticity medications during the study period
    • Score less than 6 on the Fugl-Meyer Sensory Assessment Scale for the Lower Limb
    • Cardiorespiratory or metabolic diseases (e.g. cardiac arrhythmia, uncontrolled hypertension or diabetes, chronic emphysema)
    • Unhealed decubiti, persistent infection
    • Significant cognitive or communication impairment (Mini-Mental State Examination (MMSE)<21), which could impede the understanding of the purpose of procedures of the study or prevent the patient from performing the ankle-tracking task.
    • Lesions involving the brainstem and cerebellum
    • Failure to pass the graded exercise stress test

TMS exclusion criteria

  • Implanted cardiac pacemaker
  • Metal implants in the head or face
  • Unexplained, recurring headaches
  • History of seizures or epilepsy
  • Currently under medication that could increase motor excitability and lower seizure threshold
  • Skull abnormalities or fractures
  • Concussion within the last 6 months
  • Currently pregnant

tDCS exclusion criteria

  • Skin hypersensitivity
  • History of contact dermatitits
  • History of allodynia and/or hyperalgesia
  • Any other skin or scalp condition that could be aggravated by tDCS

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Triple

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Priming+HIISTT

Facilitatory transcranial direct current stimulation (tDCS) and ankle motor training before high intensity interval speed based treadmill training

1 mA tDCS

Visuomotor target tracking task

Each treadmill session to include warm-up, high intensity speed-based intervals interleaved with active recovery, and cool down.

Comparador falso: Sham+HIISTT

Sham tDCS before high intensity interval speed based treadmill training

Each treadmill session to include warm-up, high intensity speed-based intervals interleaved with active recovery, and cool down.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Walking speed with 10 meter walk test
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up

Self-selected and fastest gait speed will be measured as the average of 3 trials of the 10-m walk test (10MWT).

Change from baseline to immediately after training and baseline to 3 months follow up

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Walking spatiotemporal characteristics with GAITRite walkway
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up

Spatiotemporal parameters of walking will be assessed using a 7m long pressure sensitive mat (GAITRite walkway).

Change from baseline to immediately after training and baseline to 3 months follow up
Motor impairment with Fugl Meyer Lower Extremity Scale
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up

Lower extremity impairment will be measured using the Fugl Meyer Lower Extremity Scale (FMLE), a series of tests of movement, reflex activity, coordination/speed, sensation, and range of motion. The maximum score is 34 and a high score indicates less impairment

Change from baseline to immediately after training and baseline to 3 months follow up
Walking endurance with 6-minute walk test
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up

Walking endurance will be measured using the 6-Minute Walk test. Participants will walk as far as possible within 6 minutes.

Change from baseline to immediately after training and baseline to 3 months follow up
Ankle range of motion
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up

Ankle range of motion will be measured using a wireless electrogoniometer affixed to the ankle.

Change from baseline to immediately after training and baseline to 3 months follow up
Ankle motor control
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up

The participant will track a computer-generated sinusoidal target with ankle dorsiflexion and plantarflexion in a custom-built ankle-tracking device. Accuracy of tracking the target with ankle motion will be calculated.

Change from baseline to immediately after training and baseline to 3 months follow up
Balance with mini Balance Evaluations Systems Test (miniBESTest)
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up.

Balance will be tested with the Mini-BESTest, involving 14 different tasks to challenge balance.

Change from baseline to immediately after training and baseline to 3 months follow up.
Aerobic capacity
Periodo de tiempo: Change from baseline to immediately after training.

Cardiopulmonary exercise tests will be performed on a motorized treadmill following an individualized protocol using standard procedures. Measures relating to peak oxygen consumption (VO2 max) will be calculated.

Change from baseline to immediately after training.
Quality of Life with EuroQol-5D (EQ-5D)
Periodo de tiempo: Change from baseline to immediately after training.

Quality of life will be measured with the EuroQol-5D (EQ-5D), a questionnaire with questions designed to assess aspects of quality of life.

Change from baseline to immediately after training.
Disability with Modified Rankin Scale
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up.

Global disability will be measured with the modified Rankin Scale, a simple 0-6 rating scale.

Change from baseline to immediately after training and baseline to 3 months follow up.
Community ambulation with wearable sensors
Periodo de tiempo: Change from baseline to immediately after training.

Daily ambulation will be assessed using an accelerometer.

Change from baseline to immediately after training.
Serum brain derived neurotrophic growth factor (BDNF)
Periodo de tiempo: Change from baseline to immediately after training.

5 ml of blood will be collected from a vein in the participants' arms

Change from baseline to immediately after training.
Corticomotor excitability using transcranial magnetic stimulation
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up.

Corticomotor excitability of the paretic and non-paretic lower limb muscles such as the tibialis anterior and soleus muscle representations will be measured with single pulse transcranial magnetic stimulation (TMS).

Change from baseline to immediately after training and baseline to 3 months follow up.
Cognitive function using Mini Mental Screening Examination
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up.

30-point questionnaire used to capture orientation, attention, memory and language.

Change from baseline to immediately after training and baseline to 3 months follow up.
Depression using Patient Health Questionnaire-9 (PHQ-9)
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up.

The 9-point questionnaire is used to measure degree of depression.

Change from baseline to immediately after training and baseline to 3 months follow up.
Modified Ashworth Scale
Periodo de tiempo: Change from baseline to immediately after training and baseline to 3 months follow up.

The modified Ashworth scale is a muscle tone assessment scale used to assess the resistance experienced during passive range of motion,

Change from baseline to immediately after training and baseline to 3 months follow up.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Sangeetha Madhavan, University of Illinois Chicago

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de septiembre de 2020

Finalización primaria (Actual)

30 de septiembre de 2026

Finalización del estudio (Actual)

30 de septiembre de 2026

Fechas de registro del estudio

Enviado por primera vez

9 de julio de 2020

Primero enviado que cumplió con los criterios de control de calidad

15 de julio de 2020

Publicado por primera vez (Actual)

20 de julio de 2020

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Palabras clave

Otros números de identificación del estudio

  • 2020-0502

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .